Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype Journal Article


Authors: Simpson, B. S.; Camacho, N.; Luxton, H. J.; Pye, H.; Finn, R.; Heavey, S.; Pitt, J.; Moore, C. M.; Whitaker, H. C.
Article Title: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype
Abstract: Large-scale genetic aberrations that underpin prostate cancer development and progression, such as copy-number alterations (CNAs), have been described but the consequences of specific changes in many identified loci is limited. Germline SNPs in the 3q26.31 locus are associated with aggressive prostate cancer, and is the location of NAALADL2, a gene overexpressed in aggressive disease. The closest gene to NAALADL2 is TBL1XR1, which is implicated in tumour development and progression. Using publicly-available cancer genomic data we report that NAALADL2 and TBL1XR1 gains/amplifications are more prevalent in aggressive sub-types of prostate cancer when compared to primary cohorts. In primary disease, gains/amplifications occurred in 15.99% (95% CI: 13.02–18.95) and 14.96% (95% CI: 12.08–17.84%) for NAALADL2 and TBL1XR1 respectively, increasing in frequency in higher Gleason grade and stage tumours. Gains/amplifications result in transcriptional changes and the development of a pro-proliferative and aggressive phenotype. These results support a pivotal role for copy-number gains in this genetic region. © 2020, The Author(s).
Journal Title: Communications Biology
Volume: 3
ISSN: 2399-3642
Publisher: Springer Nature  
Date Published: 2020-08-14
Start Page: 440
Language: English
DOI: 10.1038/s42003-020-01175-x
PUBMED: 32796921
PROVIDER: scopus
PMCID: PMC7429505
DOI/URL:
Notes: Article -- Erratum issued, see DOI 10.1038/s42003-020-01291-8 -- Export Date: 1 September 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors